Copolymer Nanoparticles for Drug Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing copolymers with hydrophilic PEG and hydrophobic polystyrene segments containing cyclic nitroxide radicals face challenges in efficiently encapsulating drugs, particularly under conditions that could affect drug activity, and lack stability in acidic environments.
Innovation Solution
A copolymer with a hydrophilic PEG segment and a hydrophobic polystyrene segment, where a trialkoxysilyl group is covalently bonded to the cyclic nitroxide radical in the side chain, forms stable nanoparticles when treated with tetraalkoxysilane or nanosized silica, enabling efficient encapsulation of physiologically active substances at ambient temperatures or lower.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If copolymers with cyclic nitroxide radicals are used to form nanoparticles, then radical scavenging function and stability are improved, but drug encapsulation efficiency deteriorates
Solution Approach 1:
The patent combines organic copolymer segments (PEG-polystyrene with cyclic nitroxide radicals) with inorganic silica to create hybrid nanoparticles. This composite structure integrates the radical scavenging function and stability of the copolymer with the drug encapsulation capability of silica, resolving the contradiction between stability and encapsulation efficiency
Solution Approach 2:
The patent structures the nanoparticles with the copolymer forming the outer shell and silica forming the inner core, creating a nested configuration. The drug is encapsulated within the silica core, while the copolymer shell provides stability and radical scavenging protection, allowing both functions to coexist effectively
2Productivity
If conventional nanoparticle systems are used, then drug encapsulation is achieved, but stability under acidic conditions deteriorates
Solution Approach 1:
The hybrid organic-inorganic structure combines the acid resistance of silica with the protective copolymer shell, creating nanoparticles that maintain both drug encapsulation capability and enhanced stability under acidic conditions
3Productivity
If high temperature treatment is used for nanoparticle formation, then encapsulation efficiency is improved, but drug activity deteriorates
Solution Approach 1:
The patent changes the temperature parameter from conventional high temperature processing to ambient temperature or lower, achieving effective drug encapsulation without subjecting the drug to thermal stress that could cause degradation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The copolymer forms stable silica-containing redox nanoparticles that efficiently encapsulate drugs, maintaining stability under high ionic strength and acidic conditions, and effectively delivers the active substance with enhanced bioavailability and reduced toxicity.
Implementation Method 1
stable nanoparticles are formed in various types of solutions due to crosslinking of the copolymer per se
Implementation Method 2
cyclic nitroxide radical having a radical scavenging function and a trialkoxysilane are covalently bonded... demonstrated to be able to prevent or treat various types of disorders considered to be caused by the excess production or presence of active oxygen in the living body by using a redox mechanism
Implementation Method 3
Copolymers in which a hydrophilic segment is composed of polyethylene glycol (PEG) and a hydrophobic segment is composed of polystyrene... have been confirmed to be able to prevent or treat various types of disorders
Data Source
AI summary
A copolymer which includes hydrophilic and hydrophobic blocks, which can form nanoparticles in which a physiologically active substance can be efficiently packaged therein and which are stable under acidic conditions. The hydrophilic segment of the copolymer is composed of polyethylene glycol (PEG) and the hydrophobic segment is composed of polystyrene. The hydrophobic segment has a side chain, and the side chain has ends to which a cyclic nitroxide radical having a radical scavenging function and a trialkoxysilane are covalently bonded.